EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $211 | -69.8% | 62 | -34.7% | 0.00% | – |
Q2 2023 | $698 | -12.5% | 95 | +23.4% | 0.00% | – |
Q1 2023 | $798 | -12.2% | 77 | 0.0% | 0.00% | – |
Q4 2022 | $909 | -9.1% | 77 | +24.2% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 62 | +129.6% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 27 | -44.9% | 0.00% | – |
Q1 2022 | $2,000 | -77.8% | 49 | -75.7% | 0.00% | – |
Q4 2021 | $9,000 | +800.0% | 202 | +676.9% | 0.00% | – |
Q3 2021 | $1,000 | -66.7% | 26 | -48.0% | 0.00% | – |
Q2 2021 | $3,000 | – | 50 | +900.0% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 5 | -76.2% | 0.00% | – |
Q4 2020 | $2,000 | – | 21 | +110.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 10 | -91.2% | 0.00% | – |
Q4 2019 | $6,000 | 0.0% | 114 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $6,000 | -45.5% | 114 | -50.0% | 0.00% | 0.0% |
Q2 2019 | $11,000 | -8.3% | 228 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $12,000 | -7.7% | 228 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $13,000 | -13.3% | 228 | -2.6% | 0.00% | 0.0% |
Q3 2018 | $15,000 | – | 234 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |